Karah Parschauer - Sep 12, 2025 Form 4 Insider Report for Ultragenyx Pharmaceutical Inc. (RARE)

Role
EVP and Chief Legal Officer
Signature
/s/ Karah Parschauer
Stock symbol
RARE
Transactions as of
Sep 12, 2025
Transactions value $
-$76,367
Form type
4
Date filed
9/12/2025, 04:11 PM
Previous filing
May 30, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Parschauer Karah Herdman EVP and Chief Legal Officer C/O ULTRAGENYX PHARMACEUTICAL INC., 60 LEVERONI COURT, NOVATO /s/ Karah Parschauer 2025-09-12 0001677455

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RARE Common Stock Sale -$76.4K -2.45K -3.24% $31.17 73.3K Sep 12, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 434 shares acquired under the Company's A&R 2014 Employee Stock Purchase Plan on April 30, 2025.
F2 Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.